Skip to main content

Pancreatitis clinical trials at UCSF
2 in progress, 0 open to new patients

  • A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis

    Sorry, not yet accepting patients

    Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia. Determine if systemic mediators of inflammation are reduced in patients receiving IV ketorolac following ERCP.

    San Francisco, California and other locations

  • Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation

    Sorry, in progress, not accepting new patients

    The study will be a phase 2/3, multicenter, double-blind, parallel assignment study. It will involve 100 adult recipients of an intra-hepatic pancreatic Islet Auto-Transplantation (IAT). The objective of this clinical trial is to assess whether reparixin leads to improved transplant outcome as measured by the proportion of insulin-independent patients following IAT. The safety of reparixin in the specific clinical setting will be also evaluated.

    San Francisco, California and other locations